- Prednisolone has been assigned to pregnancy category C by the FDA.
- Some animal studies have revealed evidence of fetal harm, although data are conflicting
- No controlled data in human pregnancy
- Is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk
Evidence of Cases Reported
- In the Michigan Medicaid Birth Defects Study involving 229,101 pregnancies from 1985 to 1992, there were 143 first trimester exposures to prednisolone
- A statistically significant increase in the total number of birth defects was found, with eleven cases reported compared with only six cases expected.
- However, no association between prednisolone and the six categories of defects studied (cardiovascular, oral clefts, spina bifida, polydactylies, limb reduction defects/syndactylies, hypospadias) was found
Oral Glucocorticosteroid
- Because of their importance in the treatment of a variety of inflammatory conditions, systemic glucocorticoids have been used fairly extensively during pregnancy
- However, it is difficult to exclude an adverse pregnancy effect due to asthma in studies of patients with asthma symptoms severe enough to require oral glucocorticoids.
- potential gestational risks of oral glucocorticoids must be balanced against the risks to the mother or the infant of inadequately treated disease.
- risks of severe uncontrolled disease are generally considered to be the greater risk, suggesting that oral glucocorticoids should still be used when indicated
Inhaled Glucocorticosteroid
- In contrast to oral/systemic glucocorticoids, the safety data on inhaled glucocorticoids are reassuring
- One study assessed 84 pregnant women who were managed with or without inhaled beclomethasone after discharge following an asthma hospitalization during pregnancy . Use of this medication significantly decreased the rate of readmission for asthma (12 versus 33 percent), and no adverse events or outcomes were reported
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.